These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 17048488)

  • 1. SiRNA drug delivery by biodegradable polymeric nanoparticles.
    Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
    J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
    Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric nanoparticles for siRNA delivery and gene silencing.
    Patil Y; Panyam J
    Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
    Khan A; Benboubetra M; Sayyed PZ; Ng KW; Fox S; Beck G; Benter IF; Akhtar S
    J Drug Target; 2004 Jul; 12(6):393-404. PubMed ID: 15545089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
    Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP
    Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
    Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
    Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
    Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S
    Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
    Tahara K; Yamamoto H; Hirashima N; Kawashima Y
    Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced delivery of biodegradable mPEG-PLGA-PLL nanoparticles loading Cy3-labelled PDGF-BB siRNA by UTMD to rat retina.
    DU J; Sun Y; Li FH; DU LF; Duan YR
    J Biosci; 2017 Jun; 42(2):299-309. PubMed ID: 28569253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
    Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
    Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
    Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
    J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicompartmental particles for combined imaging and siRNA delivery.
    Misra AC; Bhaskar S; Clay N; Lahann J
    Adv Mater; 2012 Jul; 24(28):3850-6. PubMed ID: 22581730
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
    Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
    J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
    Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
    Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid nano-in-nanoparticles for potential delivery of siRNA.
    Amsalem O; Nassar T; Benhamron S; Lazarovici P; Benita S; Yavin E
    J Control Release; 2017 Jul; 257():144-155. PubMed ID: 27215702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
    Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
    J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.